ACLY and cerebral infarction: The present results suggest that antiphospholipid antibodies should be regarded as a risk factor for juvenile cerebral infarction and that PS and PI, in addition to β2-GPI aCL and LA, should be included in the routine tests conducted in patients with cerebral infarction of unknown cause.